Peter Kuipers - 08 May 2024 Form 3 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: Chief Financial Officer
Signature: Peter J. Rivas as attorney-in-fact for Peter Kuipers
Issuer symbol: CLOV
Transactions as of: 08 May 2024
Transactions value $: $0
Form type: 3
Filing time: 10 May 2024, 16:15:04 UTC
Previous filing: 03 Nov 2023
Next filing: 01 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CLOV	Class A Common Stock						6.85M	08 May 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported number of securities beneficially owned represents 6,849,315 shares of Class A common stock of Clover Health Investments, Corp. underlying unvested time-based restricted stock units as of May 8, 2024, the effective date of the Reporting Person's appointment as Chief Financial Officer. Twenty-five percent of the restricted stock units vest on the first anniversary of April 29, 2024, and thereafter, the remaining RSUs shall vest on a quarterly basis ending on April 29, 2028, subject to the Reporting Person's continued employment on each such vesting date.

Content

The reported number of securities beneficially owned represents 6,849,315 shares of Class A common stock of Clover Health Investments, Corp. underlying unvested time-based restricted stock units as of May 8, 2024, the effective date of the Reporting Person's appointment as Chief Financial Officer. Twenty-five percent of the restricted stock units vest on the first anniversary of April 29, 2024, and thereafter, the remaining RSUs shall vest on a quarterly basis ending on April 29, 2028, subject to the Reporting Person's continued employment on each such vesting date.

Remarks:

Ex. 24 - Power of Attorney